Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -47.96% is 12% below its 3-year average of -42.76%, around the middle of its 3-year range (-69.32%–-21.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.10% above its 12-month average of -53.35%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -47.96%.
RETURN ON INVESTED CAPITAL (ROIC)
-47.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-53.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-44.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.10%
CURRENT VS 3Y AVG
-7.96%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 551 covered companies
CURRENT VS SECTOR MEDIAN
-51.67%
vs the sector median at left
ArriVent BioPharma, Inc.
Market Cap
$1.33B
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-53.35%
3Y Avg
-44.42%
5Y Avg
N/A
Market Cap
$1.32B
Return on Invested Capital (ROIC)
-40.47%
TTM Avg
-45.26%
3Y Avg
-38.46%
5Y Avg
-34.74%
Market Cap
$1.34B
Return on Invested Capital (ROIC)
-38.09%
TTM Avg
-38.09%
3Y Avg
-38.09%
5Y Avg
-38.09%
Market Cap
$1.35B
Return on Invested Capital (ROIC)
-24.52%
TTM Avg
-24.52%
3Y Avg
-24.52%
5Y Avg
-24.52%
Market Cap
$1.40B
Return on Invested Capital (ROIC)
-99.35%
TTM Avg
-175.72%
3Y Avg
-121.81%
5Y Avg
-100.94%
Market Cap
$1.43B
Return on Invested Capital (ROIC)
47.55%
TTM Avg
-5.71%
3Y Avg
-17.68%
5Y Avg
-14.30%
Market Cap
$1.22B
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-57.11%
3Y Avg
-57.11%
5Y Avg
-57.11%
Market Cap
$1.21B
Return on Invested Capital (ROIC)
1.32%
TTM Avg
13.41%
3Y Avg
0.51%
5Y Avg
-22.96%
Market Cap
$1.22B
Return on Invested Capital (ROIC)
1.12%
TTM Avg
-4.20%
3Y Avg
-6.46%
5Y Avg
-10.06%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | $1.33B | -47.96% | -53.35% | -44.42% | N/A |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.32B | -40.47% | -45.26% | -38.46% | -34.74% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.34B | -38.09% | -38.09% | -38.09% | -38.09% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.35B | -24.52% | -24.52% | -24.52% | -24.52% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | -99.35% | -175.72% | -121.81% | -100.94% |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 47.55% | -5.71% | -17.68% | -14.30% |
| Kardigan, Inc. (KARD)vs › | $1.22B | -57.11% | -57.11% | -57.11% | -57.11% |
| MannKind Corporation (MNKD)vs › | $1.21B | 1.32% | 13.41% | 0.51% | -22.96% |
| Cronos Group Inc. (CRON)vs › | $1.22B | 1.12% | -4.20% | -6.46% | -10.06% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 9.48% | 1.29% | -3.62% | 0.10% |
ROIC
-48.0%
ROE
-44.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -47.96% |
| 2026-03-31 | -48.37% |
| 2025-12-31 | -57.79% |
| 2025-09-30 | -53.25% |
| 2025-06-30 | -59.36% |
| 2025-03-31 | -69.32% |
| 2024-12-31 | -36.60% |
| 2024-09-30 | -33.75% |
| 2024-06-30 | -29.05% |
| 2024-03-31 | -26.14% |
| 2023-12-31 | -49.24% |
| 2023-09-30 | -36.02% |
| 2023-06-30 | -30.62% |
| 2022-12-31 | -21.15% |
